CymaBay Therapeutics, Inc. ( NASDAQ:CBAY – Get Rating ) was the recipient of a significant growth in short interest in April. As of April 15th, there was short interest totalling 10,320,000 shares, a growth of 6.9% from the March 31st total of 9,650,000 shares. Based on an average trading volume of 1,800,000 shares, the days-to-cover ratio is presently 5.7 days. CymaBay Therapeutics Trading Up 2.8 % Shares of CymaBay Therapeutics stock traded up $0.28 during trading hours on Wednesday, reaching $10.

https://www.dailypolitical.com/2023/05/03/cymabay-therapeutics-inc-nasdaqcbay-sees-large-increase-in-short-interest.html

#dailypolitical